Race and ethnicity affect the distribution of molecular alterations seen in patients with non-small cell lung cancer (NSCLC). While anaplastic lymphoma kinase (ALK) alterations are known to occur in 4-5% of the population, data specific to the Hispanic population remains limited. This study describes the real-world incidence of ALK alterations in Hispanic patients with NSCLC treated at a large academic institution in Los Angeles, California, USA to further elucidate the underlying factors that shape differences in mutational profiles. 607 non-small cell lung cancer (NSCLC) patients treated at Los Angeles General Medical Center (n=172) and University of Southern California Norris Comprehensive Cancer Center (n=435) who received comprehensive genomic profiling (CGP) were evaluated from January 2015 to June 2023. Fisher’s exact test and multivariate logistic regression were incorporated for statistical analysis. Hispanic patients exhibited a higher incidence of ALK alterations (12.76%, n=18/141) compared to non-Hispanic patients (5.36%, n=23/466) (p=0.0046). Multivariate logistic regression showed Hispanic ethnicity HR 2.393 (95% CI 1.115-5.092) and age at diagnosis HR 0.9325 (95% CI 0.9081-0.9558) were significant variables in ALK alteration incidence. 55.81% (n=24) of ALK alterations were initially found via comprehensive genomic profiling (CGP). This study highlights a significantly higher incidence of ALK alterations among Hispanic patients with NSCLC, emphasizing the impact of race and ethnicity on molecular alterations. Future research is required to evaluate this trend in a larger, more diverse cohort and investigate the roles of environmental factors and tumor microenvironments in influencing ALK alteration prevalence.

This content is only available via PDF.
This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.

Article PDF first page preview

Article PDF first page preview